Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Convolutional neural network-based breast cancer risk scores, mammographic density, and serum biomarkers at baseline and change from baseline to follow-up among women enrolled in SWOG S0812, stratified by treatment arm Outcome | Timeframe | Vitamin D | Placebo | P a | No. | Mean (SD) | No. | Mean (SD): Serum 25-hydroxyvitamin D, ng/mL | Baseline | 96 | 25.43 (10.73) | 91 | 24.19 (8.59) | .382

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Effects of vitamin D supplementation on a deep learning-based mammographic evaluation in SWOG S0812

Study design awaiting verification · JNCI Cancer Spectrum · 2024

Original publication title

Effects of vitamin D supplementation on a deep learning: based mammographic evaluation in SWOG S0812

Julia E McGuinness; Garnet L Anderson; Simukayi Mutasa; Dawn L Hershman; Mary Beth Terry; Parisa Tehranifar; Danika L Lew; Monica Yee; Eric A Brown; Sebastien S Kairouz; Nafisa Kuwajerwala; Therese B Bevers; John E Doster; Corrine Zarwan; Laura Kruper; Lori M Minasian; Leslie Ford; Banu Arun; Marian L Neuhouser; Gary E Goodman; Powel H Brown; Richard Ha; Katherine D Crew

© The Author(s) 2024. Published by Oxford University Press.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Abstract

Deep learning: based mammographic evaluations could noninvasively assess response to breast cancer chemoprevention. We evaluated change in a convolutional neural network: based breast cancer risk model applied to mammograms among women enrolled in SWOG S0812, which randomly assigned 208 premenopausal high-risk women to receive oral vitamin D3 20 000 IU weekly or placebo for 12 months. We applied the convolutional neural network model to mammograms collected at baseline (n = 109), 12 months (n = 97), and 24 months (n = 67) and compared changes in convolutional neural network-based risk score between treatment groups.

Change in convolutional neural network-based risk score was not statistically significantly different between vitamin D and placebo groups at 12 months (0.005 vs 0.002, P = .875) or at 24 months (0.020 vs 0.001, P = .563). The findings are consistent with the primary analysis of S0812, which did not demonstrate statistically significant changes in mammographic density with vitamin D supplementation compared with placebo. There is an ongoing need to evaluate biomarkers of response to novel breast cancer chemopreventive agents.

Authors’ abstract

Abstract

Deep learning: based mammographic evaluations could noninvasively assess response to breast cancer chemoprevention. We evaluated change in a convolutional neural network: based breast cancer risk model applied to mammograms among women enrolled in SWOG S0812, which randomly assigned 208 premenopausal high-risk women to receive oral vitamin D3 20 000 IU weekly or placebo for 12 months. We applied the convolutional neural network model to mammograms collected at baseline (n = 109), 12 months (n = 97), and 24 months (n = 67) and compared changes in convolutional neural network-based risk score between treatment groups.

Change in convolutional neural network-based risk score was not statistically significantly different between vitamin D and placebo groups at 12 months (0.005 vs 0.002, P = .875) or at 24 months (0.020 vs 0.001, P = .563). The findings are consistent with the primary analysis of S0812, which did not demonstrate statistically significant changes in mammographic density with vitamin D supplementation compared with placebo. There is an ongoing need to evaluate biomarkers of response to novel breast cancer chemopreventive agents.

Publication and source details

Original title: Effects of vitamin D supplementation on a deep learning: based mammographic evaluation in SWOG S0812

Julia E McGuinness; Garnet L Anderson; Simukayi Mutasa; Dawn L Hershman; Mary Beth Terry; Parisa Tehranifar; Danika L Lew; Monica Yee; Eric A Brown; Sebastien S Kairouz; Nafisa Kuwajerwala; Therese B Bevers; John E Doster; Corrine Zarwan; Laura Kruper; Lori M Minasian; Leslie Ford; Banu Arun; Marian L Neuhouser; Gary E Goodman; Powel H Brown; Richard Ha; Katherine D Crew

JNCI Cancer Spectrum · 2024

Correspondence to: Julia E. McGuinness, MD, MS, Division of Hematology/Oncology, Columbia University Irving Medical Center, 161 Fort Washington Avenue, Herbert Irving Pavilion 9th Floor, Room 9-962, New York, NY 10032, USA (e-mail: jem2280@cumc.columbia.edu).© The Author(s) 2024. Published by Oxford University Press.2024https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. National Institutes of Health10.13039/100000002 National Cancer Institute10.13039/100000054 R01CA226060UG1CA189974UG1CA190002UG1CA189830UG1CA189858UG1CA189953UG1CA189960U10CA180858U10CA180828U10CA180819

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:15:11.987900+00:00

DOI: 10.1093/jncics/pkae042 · PMC11216724